Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplant Coronary Vasculopathy.

Pamboukian1, Costanzo

  • 1Rush Heart Failure and Cardiac Transplant Program, Rush Presbyterian St. Luke's Medical Center, 1725 West Harrison Street Suite 439PB, Chicago, IL 60612-3824, USA.

Current Treatment Options in Cardiovascular Medicine
|January 5, 2001
PubMed
Summary

Transplant coronary vasculopathy, a complication of heart transplantation, often presents with severe symptoms. Early detection and risk factor modification are crucial for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Heart Failure.

Current treatment options in cardiovascular medicine·2000
Same author

Myocarditis.

Current treatment options in cardiovascular medicine·2000
Same author

Characteristics of nest soil, but not geographic origin, influence cold hardiness of hatchling painted turtles.

Journal of thermal biology·2000
Same author

Quasimolecular states of 24Mg excited in the 16O+12C interaction.

Physical review. C, Nuclear physics·1994
Same author

Excitation of 24Mg states through the interaction of 85 MeV 16O ions with 12C and 24Mg targets.

Physical review. C, Nuclear physics·1991

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • The transplanted heart is denervated, meaning classic angina is rarely a symptom of allograft coronary vasculopathy.
  • Symptoms like decreased exercise capacity, shortness of breath, or syncope warrant thorough assessment in cardiac transplant recipients.
  • Acute myocardial infarction, heart failure, or sudden death can be the initial presentation of transplant vasculopathy.

Purpose of the Study:

  • To highlight the importance of annual evaluations for transplant coronary vasculopathy.
  • To discuss diagnostic modalities for detecting early signs of vasculopathy.
  • To outline preventive and treatment strategies for managing transplant coronary vasculopathy.

Main Methods:

  • Annual patient evaluations are recommended for transplant coronary vasculopathy.
  • Coronary angiography, while standard, is insensitive for early detection.
  • Intracoronary ultrasound in conjunction with angiography identifies intimal thickening, an early sign of vasculopathy.
  • Dobutamine echocardiography assesses ischemic burden in patients with diagnosed vasculopathy.

Main Results:

  • Transplant coronary vasculopathy is characterized by intimal thickening due to smooth muscle cell proliferation, leading to luminal narrowing.
  • Early detection is critical as symptoms can be severe and include acute myocardial infarction or sudden death.
  • Preventive measures involve aggressive management of traditional coronary risk factors.

Conclusions:

  • Annual screening and prompt assessment for symptoms are vital in heart transplant recipients.
  • Intracoronary ultrasound offers improved sensitivity for early transplant coronary vasculopathy detection.
  • Management focuses on risk factor modification, with limited treatment options once vasculopathy is established, making retransplantation the only definitive therapy.

Related Experiment Videos